A team of panelists from the Mayo Clinic review how they incorporate bispecific antibodies into their treatment paradigm for multiple myeloma.
Moderator Rafael Fonseca, MD, highlights objectives for an upcoming panel filming with experts from the Mayo Clinic centered on the incorporation of bispecifics into the multiple myeloma treatment paradigm.